In the study the investigators aim to test whether transcranial direct current stimulation (tDCS) induced pain reduction is in association with functional changes in the brain measured with magnetic resonance imaging (MRI) and also with a change in permeability of the intestinal epithelial barrier in patients with chronic inflammatory bowel diseases (IBD) Hypothesis: Transcranial direct current stimulation can reduce the perception of pain in patients with chronic inflammatory bowel diseases, which is in association with changes in the brain measured via MRI. Additionally, transcranial direct current stimulation and the induced pain reduction influence the permeability of the intestinal epithelial barrier
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
84
Sham OR active transcranial direct current stimulation over the motor cortex
Charite University Medicine
Berlin, Germany
RECRUITINGFunctional changes in the brain measured with cerebral MRI
Exploratory analyses of resting-state fMRI
Time frame: 6 weeks
Structural changes in the brain measured with cerebral MRI
Exploratory analyses of MRI with respect to DTI (diffusions tensor imaging) and VBM (voxel based morphometry)
Time frame: 6 weeks
Functional and/or structural changes in the Intestinal Epithelial Barrier measured with endoscopy of the rectum with sample-taking
Time frame: 6 weeks
Changes in pain measured with visual analogue scale
VAS , scale from 0-10
Time frame: 6 weeks
Changes in perception of pain measured with an algometer (pain pressure threshold)
continuous scale form 0 kg
Time frame: 6 weeks
Changes in questionnaire "quality of life"
questionnaire "quality of life" analyses daily activities, scale running from 32 points (worse outcome) to 224 points (best outcome)
Time frame: 6 weeks
Changes in functional symptoms using IBS-SSS
IBS-SSS: irritable bowel syndrome - severity score system , questionnaire analyses functional symptoms, score running from 0 (best outcome) until 600 points (worst outcome)
Time frame: 6 weeks
Changes in activity indices using HWI questionnaire or SCCAI questionnaire
HWI: Harvey-Bradshaw-Index, SCCAI: Simple Clinical Colitis Activity Index, scale: points: 0-20 points (low points are best outcome, high points are worst outcome)
Time frame: 6 weeks
Changes in pain catastrophizing scale questionnaire
pain catastrophizing scale questionnaire analyses subjective catastrophizing due to pain, score running from 0-52 points (low points are best outcome, high points are worst outcome)
Time frame: 6 weeks
Changes in inflammation biomarker (blood - C-reactive protein)
unit: mg/dl
Time frame: 6 weeks
Changes in inflammation biomarker (stool - calprotectin)
Unit: mg/g
Time frame: 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.